世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Global HIV Diagnostics Market Size Study & Forecast by Product (Consumables, Instruments), Mode (Self-test), Test Type and End Use, and Regional Forecasts 2022-2032
The Global HIV Diagnostics Market was valued at approximately USD 1.13 billion in 2024 and is projected to expand at a steady CAGR of around 5.00% throughout the forecast period from 2025 to 2035. ... もっと見る
SummaryThe Global HIV Diagnostics Market was valued at approximately USD 1.13 billion in 2024 and is projected to expand at a steady CAGR of around 5.00% throughout the forecast period from 2025 to 2035. HIV diagnostics encompass a comprehensive range of technologies and tests designed to detect the presence of the Human Immunodeficiency Virus in individuals, facilitating early diagnosis, monitoring, and management of the disease. The market’s upward trajectory is propelled by increasing awareness, widespread government initiatives, and heightened demand for rapid and accurate testing methods. Furthermore, the rising prevalence of HIV infections worldwide, coupled with advances in diagnostic techniques, significantly bolsters the market growth prospects. The integration of cutting-edge technologies such as molecular diagnostics and self-testing kits is also reshaping the landscape, enhancing accessibility and convenience for users globally.The growing emphasis on early detection to curb the transmission of HIV infections has led to the accelerated adoption of innovative diagnostic tools and consumables, which are indispensable in healthcare settings. According to UNAIDS, approximately 38 million people globally were living with HIV in 2023, highlighting an urgent need for scalable diagnostic solutions. Moreover, the increasing prevalence of HIV in low- and middle-income countries, combined with supportive government funding and NGO interventions, is driving substantial demand for cost-effective and easy-to-use diagnostic products. Despite some challenges such as regulatory hurdles and concerns over the accuracy of rapid tests, ongoing technological advancements and product launches are expected to overcome these barriers, offering lucrative opportunities for market players. Geographically, North America holds a dominant position in the HIV diagnostics market, attributed to its advanced healthcare infrastructure, high healthcare expenditure, and strong presence of key market players engaged in research and development. The United States leads the regional market, benefiting from extensive HIV screening programs and widespread adoption of self-testing devices. Europe follows closely, with increasing government initiatives aimed at reducing HIV incidence and enhanced reimbursement policies fostering market growth. Meanwhile, the Asia Pacific region is anticipated to emerge as the fastest-growing market due to escalating HIV awareness campaigns, rising healthcare infrastructure investments, and expanding access to diagnostic technologies in countries such as India and China. The Latin America and Middle East & Africa regions are also witnessing gradual market expansion owing to increasing collaborations between governments and international health organizations. Major market players included in this report are: • Halliburton Company • Schlumberger Limited • Croda International Plc. • Baker Hughes Company • Chevron Phillips Chemical Company • BASF SE • M&D Industries Of Louisiana, Inc. • Trican Well Service Ltd. • Aubin Group • Impact Fluid Solutions • Abbott Laboratories • Roche Diagnostics • Siemens Healthineers • Bio-Rad Laboratories • Becton, Dickinson and Company Global HIV Diagnostics Market Report Scope: • Historical Data – 2023, 2024 • Base Year for Estimation – 2024 • Forecast period – 2025-2035 • Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends • Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa • Customization Scope – Free report customization (equivalent up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope* The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below: By Product: • Consumables • Instruments By Mode: • Self-test By Test Type: • (Not further segmented here, but included as a key segment) By End Use: • (Not further segmented here, but included as a key segment) By Region: North America • U.S. • Canada Europe • UK • Germany • France • Spain • Italy • Rest of Europe (ROE) Asia Pacific • China • India • Japan • Australia • South Korea • Rest of Asia Pacific (RoAPAC) Latin America • Brazil • Mexico Middle East & Africa • UAE • Saudi Arabia • South Africa • Rest of Middle East & Africa Key Takeaways: • Market Estimates & Forecast for 10 years from 2025 to 2035. • Annualized revenues and regional level analysis for each market segment. • Detailed analysis of geographical landscape with Country level analysis of major regions. • Competitive landscape with information on major players in the market. • Analysis of key business strategies and recommendations on future market approach. • Analysis of competitive structure of the market. • Demand side and supply side analysis of the market. Table of ContentsTable of ContentsChapter 1. Global HIV Diagnostics Market Report Scope & Methodology 1.1. Research Objective 1.2. Research Methodology 1.2.1. Forecast Model 1.2.2. Desk Research 1.2.3. Top Down and Bottom-Up Approach 1.3. Research Attributes 1.4. Scope of the Study 1.4.1. Market Definition 1.4.2. Market Segmentation 1.5. Research Assumption 1.5.1. Inclusion & Exclusion 1.5.2. Limitations 1.5.3. Years Considered for the Study Chapter 2. Executive Summary 2.1. CEO/CXO Standpoint 2.2. Strategic Insights 2.3. ESG Analysis 2.4. Key Findings Chapter 3. Global HIV Diagnostics Market Forces Analysis 3.1. Market Forces Shaping The Global HIV Diagnostics Market (2024-2035) 3.2. Drivers 3.2.1. Increasing Prevalence of HIV Infections Worldwide 3.2.2. Growing Awareness and Government Initiatives for Early Detection 3.2.3. Technological Advancements in Diagnostic Tools and Self-Test Kits 3.3. Restraints 3.3.1. Regulatory Hurdles and Compliance Challenges 3.3.2. Concerns Over Accuracy of Rapid HIV Tests 3.4. Opportunities 3.4.1. Expansion in Low- and Middle-Income Countries Due to Rising Healthcare Investments 3.4.2. Integration of Molecular Diagnostics and Self-Testing for Greater Accessibility Chapter 4. Global HIV Diagnostics Industry Analysis 4.1. Porter’s 5 Forces Model 4.1.1. Bargaining Power of Buyer 4.1.2. Bargaining Power of Supplier 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.2. Porter’s 5 Force Forecast Model (2024-2035) 4.3. PESTEL Analysis 4.3.1. Political 4.3.2. Economical 4.3.3. Social 4.3.4. Technological 4.3.5. Environmental 4.3.6. Legal 4.4. Top Investment Opportunities 4.5. Top Winning Strategies (2025) 4.6. Market Share Analysis (2024-2025) 4.7. Global Pricing Analysis And Trends 2025 4.8. Analyst Recommendation & Conclusion Chapter 5. Global HIV Diagnostics Market Size & Forecasts by Product 2025-2035 5.1. Market Overview 5.2. Consumables 5.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 5.2.2. Market Size Analysis, by Region, 2025-2035 5.3. Instruments 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 5.3.2. Market Size Analysis, by Region, 2025-2035 Chapter 6. Global HIV Diagnostics Market Size & Forecasts by Mode 2025–2035 6.1. Market Overview 6.2. Self-test 6.2.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 6.2.2. Market Size Analysis, by Region, 2025-2035 Chapter 7. Global HIV Diagnostics Market Size & Forecasts by Region 2025–2035 7.1. HIV Diagnostics Market, Regional Market Snapshot 7.2. Top Leading & Emerging Countries 7.3. North America HIV Diagnostics Market 7.3.1. U.S. HIV Diagnostics Market 7.3.1.1. Product breakdown size & forecasts, 2025-2035 7.3.1.2. Mode breakdown size & forecasts, 2025-2035 7.3.2. Canada HIV Diagnostics Market 7.3.2.1. Product breakdown size & forecasts, 2025-2035 7.3.2.2. Mode breakdown size & forecasts, 2025-2035 7.4. Europe HIV Diagnostics Market 7.4.1. UK HIV Diagnostics Market 7.4.1.1. Product breakdown size & forecasts, 2025-2035 7.4.1.2. Mode breakdown size & forecasts, 2025-2035 7.4.2. Germany HIV Diagnostics Market 7.4.2.1. Product breakdown size & forecasts, 2025-2035 7.4.2.2. Mode breakdown size & forecasts, 2025-2035 7.4.3. France HIV Diagnostics Market 7.4.3.1. Product breakdown size & forecasts, 2025-2035 7.4.3.2. Mode breakdown size & forecasts, 2025-2035 7.4.4. Spain HIV Diagnostics Market 7.4.4.1. Product breakdown size & forecasts, 2025-2035 7.4.4.2. Mode breakdown size & forecasts, 2025-2035 7.4.5. Italy HIV Diagnostics Market 7.4.5.1. Product breakdown size & forecasts, 2025-2035 7.4.5.2. Mode breakdown size & forecasts, 2025-2035 7.4.6. Rest of Europe HIV Diagnostics Market 7.4.6.1. Product breakdown size & forecasts, 2025-2035 7.4.6.2. Mode breakdown size & forecasts, 2025-2035 7.5. Asia Pacific HIV Diagnostics Market 7.5.1. China HIV Diagnostics Market 7.5.1.1. Product breakdown size & forecasts, 2025-2035 7.5.1.2. Mode breakdown size & forecasts, 2025-2035 7.5.2. India HIV Diagnostics Market 7.5.2.1. Product breakdown size & forecasts, 2025-2035 7.5.2.2. Mode breakdown size & forecasts, 2025-2035 7.5.3. Japan HIV Diagnostics Market 7.5.3.1. Product breakdown size & forecasts, 2025-2035 7.5.3.2. Mode breakdown size & forecasts, 2025-2035 7.5.4. Australia HIV Diagnostics Market 7.5.4.1. Product breakdown size & forecasts, 2025-2035 7.5.4.2. Mode breakdown size & forecasts, 2025-2035 7.5.5. South Korea HIV Diagnostics Market 7.5.5.1. Product breakdown size & forecasts, 2025-2035 7.5.5.2. Mode breakdown size & forecasts, 2025-2035 7.5.6. Rest of Asia Pacific HIV Diagnostics Market 7.5.6.1. Product breakdown size & forecasts, 2025-2035 7.5.6.2. Mode breakdown size & forecasts, 2025-2035 7.6. Latin America HIV Diagnostics Market 7.6.1. Brazil HIV Diagnostics Market 7.6.1.1. Product breakdown size & forecasts, 2025-2035 7.6.1.2. Mode breakdown size & forecasts, 2025-2035 7.6.2. Mexico HIV Diagnostics Market 7.6.2.1. Product breakdown size & forecasts, 2025-2035 7.6.2.2. Mode breakdown size & forecasts, 2025-2035 7.7. Middle East and Africa HIV Diagnostics Market 7.7.1. UAE HIV Diagnostics Market 7.7.1.1. Product breakdown size & forecasts, 2025-2035 7.7.1.2. Mode breakdown size & forecasts, 2025-2035 7.7.2. Saudi Arabia (KSA) HIV Diagnostics Market 7.7.2.1. Product breakdown size & forecasts, 2025-2035 7.7.2.2. Mode breakdown size & forecasts, 2025-2035 7.7.3. South Africa HIV Diagnostics Market 7.7.3.1. Product breakdown size & forecasts, 2025-2035 7.7.3.2. Mode breakdown size & forecasts, 2025-2035 7.7.4. Rest of Middle East & Africa HIV Diagnostics Market 7.7.4.1. Product breakdown size & forecasts, 2025-2035 7.7.4.2. Mode breakdown size & forecasts, 2025-2035 Chapter 8. Competitive Intelligence 8.1. Top Market Strategies 8.2. Abbott Laboratories 8.2.1. Company Overview 8.2.2. Key Executives 8.2.3. Company Snapshot 8.2.4. Financial Performance (Subject to Data Availability) 8.2.5. Product/Services Port 8.2.6. Recent Development 8.2.7. Market Strategies 8.2.8. SWOT Analysis 8.3. Roche Diagnostics 8.4. Siemens Healthineers 8.5. Bio-Rad Laboratories 8.6. Becton, Dickinson and Company 8.7. Halliburton Company 8.8. Schlumberger Limited 8.9. Croda International Plc. 8.10. Baker Hughes Company 8.11. Chevron Phillips Chemical Company 8.12. BASF SE 8.13. M&D Industries Of Louisiana, Inc. 8.14. Trican Well Service Ltd. 8.15. Aubin Group 8.16. Impact Fluid Solutions
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
Bizwit Research & Consulting LLP社の 医薬品分野 での最新刊レポート
本レポートと同じKEY WORD（diagnostics）の最新刊レポート
よくあるご質問Bizwit Research & Consulting LLP社はどのような調査会社ですか?Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
